Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin
- PMID: 19781696
- PMCID: PMC3756311
- DOI: 10.1016/j.fertnstert.2009.08.006
Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin
Abstract
We studied the effect of metformin or placebo in a lifestyle modification program combined with oral contraceptives (OC) on quality-of-life parameters measured by the polycystic ovary syndrome (PCOS) questionnaire in obese adolescent women with validated PCOS. The quality-of-life indicators were measured at baseline and conclusion for five domains on the PCOS questionnaire, with equal improvement in scores in both placebo and metformin groups, suggesting that the addition of metformin does not add improvement to quality-of-life measures above those observed with lifestyle modification and OC treatment.
Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors report no conflicts of interest.
Figures
References
-
- Carmina EM, Azziz R. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. Fertil Steril. 2006;86(1):S7–S8. - PubMed
-
- Franks S. Medical progress: polycystic ovary syndrome. NEJM. 1995;333(13):853–861. - PubMed
-
- Trivax BM, Azziz R. Diagnosis of polycystic ovary syndrome. Clinical Obstetrics and Gynecology. 2007;50(1):168–177. - PubMed
-
- Carmina EM, Azziz R. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. Fertil Steril. 2006;86(1):S7–S8. - PubMed
-
- Yen SSC. The polycystic ovary syndrome. Clin Endocrinol (Oxf) 1980;12:177–208. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
